Schleusener Jeffrey T MD - 57701 Rapid City, SD

Business Name: Schleusener Jeffrey T MD
Categorized In: Doctors
Address: 2805 5th St # 210, Rapid City, SD 57701
Phone Number: (605) 343-2267
Contact Person: Jeffrey Schleusener
Website Address: clinlab.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: DE Paolo Hugh D MD - Rapid City, SD 57701
Rapid City Emergency Services - Rapid City, SD 57701
Parys Stephen C MD - Rapid City, SD 57701
Rapid City VA Clinic - Rapid City, SD 57701
Mindakota Neurological Pc - Rapid City, SD 57701
Yu Dylan L MD - Rapid City, SD 57701
Brekhus Michael MD - Rapid City, SD 57701
Keegan James M MD - Rapid City, SD 57701
Murray William C DO - Rapid City, SD 57701
Minton Timothy P MD - Rapid City, SD 57701
Thorson Holly MD - Rapid City, SD 57701
Miller Robert E MD - Rapid City, SD 57701
The Eye Doctors At Rapid City Medical Center Llp - Rapid City, SD 57701
Mac Lachlan Robert MD - Rapid City, SD 57701
Heilman K John MD - Rapid City, SD 57701
Benn Steven I MD - Rapid City, SD 57701
Stelzle Robert C MD - Rapid City, SD 57701
Radiology Associates - Rapid City, SD 57701
Dirks Monte MD - Rapid City, SD 57701
Preston Robert MD - Rapid City, SD 57701

Schleusener Jeffrey T MD provides professional Doctors from its single location at the coordinates 44.05804,-103.22714.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 2805 5th St # 210, Rapid City, South Dakota 57701 or contacted through representative Jeffrey Schleusener at (605) 343-2267.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Schleusener Jeffrey T MD through its company website at clinlab.com. Engage with this business on its social media platforms through on Twitter and on Facebook.